MedTrace Logo

Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy

NCT03078504 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-03-30

Study results available
· View outcomes & findings →

Summary

Purpose of this study is to evaluate the short-term hemodynamic effects of changes in blood flow rates in critically ill patients receiving continuous renal replacement therapy.

Conditions

Interventions

DEVICE

continuous renal replacement therapy using System One (TM) setup (Nxstage)

Participants who have been prescribed continuous renal replacement therapy will have hemodynamic parameters measured at various blood flow rates

Sponsors & Collaborators

  • St. Louis University

    lead OTHER

Principal Investigators

  • Zafar Jamkhana, MD · Associate Professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-17
Primary Completion
2018-06-06
Completion
2018-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078504 on ClinicalTrials.gov